603309 维力医疗
2024/09 - 九个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入1,060,4298.53%1,387,7351,363,3531,118,5711,130,679
减:营业总成本874,7917.84%1,158,7431,154,564976,072925,660
    其中:营业成本585,3789.71%750,921774,497644,731635,953
               财务费用5,766104.02%5,032(2,569)9,57218,360
               资产减值损失45-103.02%(11,716)(17,952)(6,255)(11,016)
公允价值变动收益172-91.26%761,937186--
投资收益5,4121.23%8,5324,056(1,016)(1,792)
    其中:对联营企业和合营企业的投资收益(300)-37.79%(534)(5,432)(1,611)(6)
营业利润200,74811.70%238,839206,653142,719198,267
利润总额199,18011.42%237,303205,653140,224190,112
减:所得税费用26,9830.49%32,70027,90025,54930,232
净利润172,19713.36%204,603177,753114,675159,880
减:非控股权益5,471-31.51%12,11811,1828,5816,769
股东净利润166,72615.85%192,485166,571106,093153,111

市场价值指针
每股收益 (元) *0.57016.33%0.6600.5700.4100.590
每股派息 (元) *----0.5000.3400.1350.200
每股净资产 (元) *6.2683.98%6.1985.8775.3804.362
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容